| Title | China Oncology |
| Abbreviation | China Oncol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Oncology (Q4) |
| h-index | 6 |
| Overall Rank/Ranking | 25343 |
| SCImago Journal Rank (SJR) | 0.122 |
| Impact Score | 0.22 |
| Publisher | Editorial Office of China Oncology |
| Country | China |
| ISSN | 10073639 |
| Best Quartile | Q4 |
| Coverage History | 2020-2023 |
China Oncology is a journal covering the technologies/fields/categories related to Oncology (Q4). It is published by Editorial Office of China Oncology. The overall rank of China Oncology is 25343. According to SCImago Journal Rank (SJR), this journal is ranked 0.122. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 6. The best quartile for this journal is Q4.
The ISSN of China Oncology journal is 10073639. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. China Oncology is cited by a total of 81 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of China Oncology is 0.22, which is computed in 2024 as per its definition. China Oncology IF is decreased by a factor of 0.04 and approximate percentage change is -15.38% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of China Oncology is 0.22. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.22 |
| 2022 | 0.26 |
| 2021 | 0.20 |
| 2020 | 0.00 |
China Oncology has an h-index of 6. It means 6 articles of this journal have more than 6 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of China Oncology is 10073639. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of China Oncology is 25343. According to SCImago Journal Rank (SJR), this journal is ranked 0.122. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.122 |
| 2022 | 0.123 |
| 2021 | 0.110 |
| 2020 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 25343 |
| 2022 | 23949 |
| 2021 | 24368 |
| 2020 | 32953 |
China Oncology is published by Editorial Office of China Oncology. It's publishing house is located in China. Coverage history of this journal is as following: 2020-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of China Oncology is China Oncol.. This abbreviation ('China Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Oncology (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
China Oncology latest impact IF is 0.22. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 0.26 (2022) and 0.00 (2020), respectively, in the last 4 years. Moreover, its average IS is 0.17 in the previous 4 years.
The China Oncology has an SJR (SCImago Journal Rank) of 0.122, according to the latest data. It is computed in the year 2024. In the past 4 years, this journal has recorded a range of SJR, with the highest being 0.123 in 2022 and the lowest being in 2020. Furthermore, the average SJR of the China Oncology over the previous 4-year period stands at 0.17.
The latest h-index of the China Oncology is 6.
The China Oncology is published by the Editorial Office of China Oncology, with its country of publication being the China.
The China Oncology is currently ranked 25343 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 4 years, this journal has experienced varying rankings, reaching its highest position of 23949 in 2022 and its lowest position of 32953 in 2020.
The standard ISO4 abbreviation for the China Oncology is China Oncol..
China Oncology is classified as a journal that the Editorial Office of China Oncology publishes.
The China Oncology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The China Oncology is assigned the following International Standard Serial Numbers (ISSN): 10073639.
The best quartile for the China Oncology is Q4 (2023).
The China Oncology coverage history can be summarized as follows: 2020-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Indian Journal of Plastic Surgery | journal | 13847 | Thieme Medical Publishers, Inc. | 40 | 0.59 |
| Business: Theory and Practice | journal | 14643 | Vilnius Gediminas Technical University | 26 | 2.37 |
| Journal of Competition Law and Economics | journal | 10133 | Oxford University Press | 30 | 0.96 |
| Air and Space Power Journal (discontinued) | journal | 28397 | AU Press | 9 | 0.20 |
| Canadian Journal of Education | journal | 18985 | Canadian Society for the Study of Education (CSSE) | 43 | 0.58 |
| International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS | conference and proceedings | 678 | Association for Computing Machinery (ACM) | 106 | 7.58 |
| Archives of the Balkan Medical Union | journal | 23592 | Balkan Medical Union | 12 | 0.21 |
| Oral Radiology | journal | 8912 | Springer Japan | 23 | 2.13 |
| European Journal of Cancer, Supplement | journal | 6710 | Elsevier Ltd | 29 | 0.33 |
| Rudarsko Geolosko Naftni Zbornik | journal | 13873 | 19 | 1.48 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 0.22 |
| 2022 | 0.26 |
| 2021 | 0.20 |
| 2020 | 0.00 |
